Contacts:
Director, Research and Development
Head of Business Development, Drug Development Support, Worldwide

drug development support

'Combining the sensitivity and specificity of molecular diagnostics with the power of image analysis and morphometry to redefine the clinical management of cancer and other diseases.'

introduction

Medical Solutions™ drug development support offers state of the art tissue analysis laboratories, which provide prognostic, diagnostic and therapeutic testing to support drug discovery. Our fast throughput staining and image analysis platform can provide pharmaceutical and biotechnology companies with rapid, high quality results, to facilitate the identification of biomarkers most closely linked with response to therapy during clinical trials. Medical Solutions™ also provides leading edge support, utilising the most advanced scientific knowledge and molecular biology techniques in the development of new surrogate biomarkers for cancer and other therapeutic areas, including inflammatory diseases, and respiratory, CNS, cardiovascular and metabolic disorders.

Our services include target validation, characterisation of antibodies, distribution analysis of novel antigens and potential drug targets, as well as quantitation of therapeutically relevant markers in cellular compartments and cells of different tissues.

This work can be undertaken using Medical Solutions™ or client sourced biomaterials since many of these highly specialised projects can only be conducted on consented human tissue. Tissue for pre-clinical studies can also be provided. Medical Solutions™ serves a broad spectrum of pharmaceutical and biotechnology clients worldwide. Our services and diagnostic tests provide superior support for research and development efforts as well as clinical trials. Medical Solutions Scientific Advisory Board comprises leaders in the field of pathology, oncology and research.